Logo image of LOVE.CA

CANNARA BIOTECH INC (LOVE.CA) Stock Fundamental Analysis

TSX-V:LOVE - TSX Venture Exchange - CA13765U2002 - Common Stock - Currency: CAD

1.31  +0.06 (+4.8%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to LOVE. LOVE was compared to 5 industry peers in the Personal Care Products industry. LOVE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LOVE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year LOVE was profitable.
LOVE had a positive operating cash flow in the past year.
In multiple years LOVE reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: LOVE reported negative operating cash flow in multiple years.
LOVE.CA Yearly Net Income VS EBIT VS OCF VS FCFLOVE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

LOVE's Return On Assets of 4.12% is fine compared to the rest of the industry. LOVE outperforms 75.00% of its industry peers.
LOVE has a Return On Equity of 7.33%. This is in the better half of the industry: LOVE outperforms 75.00% of its industry peers.
Industry RankSector Rank
ROA 4.12%
ROE 7.33%
ROIC N/A
ROA(3y)3.63%
ROA(5y)-2.7%
ROE(3y)6.49%
ROE(5y)-3.09%
ROIC(3y)N/A
ROIC(5y)N/A
LOVE.CA Yearly ROA, ROE, ROICLOVE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

The Profit Margin of LOVE (7.56%) is better than 100.00% of its industry peers.
With a Gross Margin value of 7.74%, LOVE is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
LOVE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 7.56%
GM 7.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.07%
GM growth 5Y-41.26%
LOVE.CA Yearly Profit, Operating, Gross MarginsLOVE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

6

2. Health

2.1 Basic Checks

LOVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LOVE has less shares outstanding
The number of shares outstanding for LOVE has been increased compared to 5 years ago.
Compared to 1 year ago, LOVE has an improved debt to assets ratio.
LOVE.CA Yearly Shares OutstandingLOVE.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LOVE.CA Yearly Total Debt VS Total AssetsLOVE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.40, we must say that LOVE is in the distress zone and has some risk of bankruptcy.
LOVE has a better Altman-Z score (1.40) than 75.00% of its industry peers.
LOVE has a debt to FCF ratio of 4.52. This is a neutral value as LOVE would need 4.52 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.52, LOVE belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.44 indicates that LOVE is not too dependend on debt financing.
The Debt to Equity ratio of LOVE (0.44) is better than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 4.52
Altman-Z 1.4
ROIC/WACCN/A
WACC7%
LOVE.CA Yearly LT Debt VS Equity VS FCFLOVE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

LOVE has a Current Ratio of 2.01. This indicates that LOVE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.01, LOVE is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
A Quick Ratio of 0.86 indicates that LOVE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.86, LOVE is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 0.86
LOVE.CA Yearly Current Assets VS Current LiabilitesLOVE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

LOVE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.67%.
LOVE shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.47%.
The Revenue has been growing by 108.26% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-28.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.62%
Revenue 1Y (TTM)31.47%
Revenue growth 3Y68.19%
Revenue growth 5Y108.26%
Sales Q2Q%28.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LOVE.CA Yearly Revenue VS EstimatesLOVE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LOVE.CA Yearly EPS VS EstimatesLOVE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.71, the valuation of LOVE can be described as rather expensive.
Based on the Price/Earnings ratio, LOVE is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of LOVE to the average of the S&P500 Index (29.35), we can say LOVE is valued slightly cheaper.
Industry RankSector Rank
PE 18.71
Fwd PE N/A
LOVE.CA Price Earnings VS Forward Price EarningsLOVE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, LOVE is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.96
EV/EBITDA N/A
LOVE.CA Per share dataLOVE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LOVE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANNARA BIOTECH INC

TSX-V:LOVE (3/7/2025, 7:00:00 PM)

1.31

+0.06 (+4.8%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)01-27 2025-01-27
Earnings (Next)04-25 2025-04-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners27.69%
Ins Owner ChangeN/A
Market Cap118.74M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.71
Fwd PE N/A
P/S 1.35
P/FCF 10.96
P/OCF 7.35
P/B 1.31
P/tB 1.31
EV/EBITDA N/A
EPS(TTM)0.07
EY5.34%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.12
FCFY9.12%
OCF(TTM)0.18
OCFY13.61%
SpS0.97
BVpS1
TBVpS1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.12%
ROE 7.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 7.56%
GM 7.74%
FCFM 12.35%
ROA(3y)3.63%
ROA(5y)-2.7%
ROE(3y)6.49%
ROE(5y)-3.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.07%
GM growth 5Y-41.26%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 4.52
Debt/EBITDA N/A
Cap/Depr 84.71%
Cap/Sales 6.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 163.24%
Current Ratio 2.01
Quick Ratio 0.86
Altman-Z 1.4
F-Score5
WACC7%
ROIC/WACCN/A
Cap/Depr(3y)228.25%
Cap/Depr(5y)410.31%
Cap/Sales(3y)22.24%
Cap/Sales(5y)120%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.62%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.47%
Revenue growth 3Y68.19%
Revenue growth 5Y108.26%
Sales Q2Q%28.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-56.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y148.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y348.38%
OCF growth 3YN/A
OCF growth 5YN/A